Harrow, Inc. Capital Leases, Future Minimum Payments Due in Two Years
Harrow, Inc. (HROW) had Capital Leases, Future Minimum Payments Due in Two Years of $751.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2018-11-13
- 2018-09-30: Capital Leases, Future Minimum Payments Due in Two Years $751.00K.
- 2018-06-30: Capital Leases, Future Minimum Payments Due in Two Years $751.00K.
- 2018-03-31: Capital Leases, Future Minimum Payments Due in Two Years $751.00K.
- 2017-12-31: Capital Leases, Future Minimum Payments Due in Two Years $751.00K.
| Period end | Capital Leases, Future Minimum Payments Due in Two Years |
|---|---|
| 2018-09-30 | $751.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $751.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $751.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $751.00K 10-K · filed 2018-03-08 |
| 2017-09-30 | $773.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $773.00K 10-Q · filed 2017-08-10 |
| 2017-03-31 | $773.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $773.00K 10-K · filed 2017-03-21 |
| 2016-09-30 | $773.00K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $1.00K 10-K · filed 2016-03-23 |
| 2015-09-30 | $1.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $19.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $19.32K 10-K · filed 2015-03-12 |
| 2014-09-30 | $25.48K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $7.01K 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |